What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY?
- Resource Type
- Article
- Source
- In
Value in Health March 2018 21(3):341-350 - Subject
- Language
- ISSN
- 1098-3015